Orthocell Ltd has released a press release.
First Patients Complete Nerve Regeneration Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Orthocell
- Orthocell Submits AUS Regulatory Application for CelGro
- Orthocells Ortho-ATI shows 82% success rate
- CelGro Approved in Key UK Public Dental Hospital
- Share Placement Successfully Raises $1.8m
- Patient Treatment Completed in Dental Implant Study
Later from Orthocell
- Orthocell announces successful capital raising
- CelGro Accelerates Dental Implant Treatments
- CelGro Study Validates High Quality Nerve Repair
- Successful CelGro Tendon Regeneration Trial
- CelGro Nerve Regeneration Results in Quadriplegic Patients
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell